Table 1.
Clinical characteristics of patients and controls
| Control Group | PCOS Group | p | |||
|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | ||||
| Age (years) | 25,63 | 7,67 | 24,44 | 5,69 | 0,567 |
| Weight | 60,43 | 15,37 | 66,17 | 16,08 | 0,099 |
| BMI (k/m2) | 24,25 | 7,68 | 24,80 | 5,88 | 0,436 |
| HCY μmol/ml. | 10,90 | 3,60 | 12,37 | 4,05 | 0,073 |
| MDA (nMol/ml) | 6,47 | 3,63 | 5,59 | 2,55 | 0,396 |
| NO (microMol/L) | 8,73 | 3,04 | 9,54 | 4,16 | 0,595 |
| SH (mMol/L) | 6,96 | 6,07 | 10,92 | 7,76 | 0,172 |
| TAFI | 9,89 | 5,06 | 12,14 | 10,01 | 0,563 |
| Fasting Glucose (mg/dl) | 84,39 | 18,27 | 91,79 | 8,99 | 0,005 |
| Fasting insulin (mIU/ml) | 11,09 | 21,22 | 15,78 | 33,23 | 0,507 |
| Homocysteine (μmol/L) | 1,27 | 1,24 | 3,83 | 9,17 | 0,168 |
| Estradiol (pg/ml) | 51,65 | 58,40 | 35,13 | 26,82 | 0,052 |
| DHEA-S (μg/dl) | 272,93 | 131,36 | 217,19 | 115,69 | 0,035 |
| 17 -OHP (ng/ml) | 1,10 | 1,05 | 1,85 | 1,04 | 0,002 |
| Total-Testosterone (ng/ml) | 0,92 | 1,30 | 0,96 | 1,85 | 0,905 |
| Free-Testosterone (pg/ml) | 1,76 | 0,83 | 3,28 | 2,12 | 0,001 |
| Prolactin (pmol) | 17,09 | 10,76 | 17,01 | 8,00 | 0,969 |
| Total-cholesterol (mg/dl) | 171,34 | 61,74 | 198,95 | 41,19 | 0,009 |
| Triglycerides (mg/dl) | 88,52 | 50,83 | 124,00 | 69,35 | 0,014 |
| HDL-C (mg/dl) | 59,37 | 16,39 | 57,06 | 15,39 | 0,514 |
| LDL-C (mg/dl) | 98,89 | 31,83 | 117,68 | 31,71 | 0,01 |
| Fibrinogen (mg/dl) | 295,85 | 102,07 | 373,83 | 110,84 | 0,004 |